December 21, 2022
Jessica Thaxton, PhD, MsCR, and colleagues found that targeting key proteins that control the T cell response to stress could help researchers develop more potent cancer immunotherapies.
December 9, 2022
UNC Lineberger researchers will present the latest findings from studies and lead educational sessions at the 64th American Society of Hematology Annual Meeting in New Orleans, Dec. 10-13.
November 18, 2022
Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2022 Highly Cited Researchers list.
October 7, 2022
UNC named UNC Lineberger’s Yuliya Pylayeva-Gupta, PhD, one of four recipients of the Phillip and Ruth Hettleman Prize for Artistic and Scholarly Achievement.
October 6, 2022
UNC Lineberger researchers have found a possible way to overcome barriers that block anti-cancer immune responses. Their findings could have implications for treating solid tumors, including breast and pancreatic cancer.
July 22, 2022
The UNC RNA Discovery Center, led by Chad Pecot, MD, will cultivate an inclusive community of scientists dedicated to investigating all aspects of RNA biology.
July 14, 2022
Inspired by the potential of immunotherapy in solid tumor cancers, Tom and Nancy Chewning established a fund to support Jonathan Serody, MD, and accelerate his work with CAR-T immunotherapy.
May 6, 2022
UNC Lineberger's Ralph Baric, PhD, and Jenny P. Ting, PhD, have been elected to the American Academy of Arts and Sciences. They join seven other UNC Lineberger members with this honor.
March 24, 2022
Yevgeny Brudno, PhD, and colleagues from NC State University and UNC-Chapel Hill have developed an implantable biotechnology that produces and releases CAR-T for attacking cancerous tumors.
January 11, 2022
Yuliya Pylayeva-Gupta, PhD, is a recipient of The Mark Foundation for Cancer Research Emerging Leader Award. The funding will support her research focused on reprogramming B cell fate and function in cancer.
